Skip to main content
Caplight Logo









BioThrust

BioThrust

Private
AachenHealthcare & Life Scienceshttps://www.biothrust.com/

Last Round

Grant

Feb 17, 2025

Total Funding Raised

$2.81M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

BioThrust is a biotechnology company that develops bioreactor technologies for scalable cell therapy manufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

bioreactor systemscell therapy manufacturingbubble-free aerationcell and gene therapyCGTlow-shear aerationsingle-use bioreactorbioprocessing equipmentbiopharmaceutical productionCDMOscale-up servicesMembrane Stirrerclean meatbiologics manufacturingvaccine production

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioThrust Comparables

Compare BioThrust with similar companies based on industry and business-model similarity.

BioThrust comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Limula
83%
Aglaris
83%
Scinus Cell Expansion
81%

BioThrust Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2025
SeedJan 25, 2024
GrantApr 1, 2022

Key People

Founding team and executive leadership

Moritz Meyer

Co-Founder and CTO

Founding Team

Patrick Bongartz

Co-Founder & CEO

Founding Team

BioThrust Investors

Notable investors and investment history

BioThrust investors
InvestorRounds
European Innovation Council FundGrant
Freigeist CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2026

    Open roles increased from 0 to 8, representing 26% of headcount.

  • Oct 15, 2025

    Grew 22% QoQ, from 23 to 28 employees.

BioThrust Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioThrust Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioThrust's valuation, stock price, and market status.

Firmographic Details

HeadquartersAachen
Employee Range31
Year Founded2022
Last FundingFeb 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?